Investigating specific pathological features of cerebral cavernous malformation in children

by Katie Paradis,Children's Hospital BostonCredit: CC0 Public DomainChildren with cavernous malformations face unique treatment challenges due to factors such as the malformation's locat

Updated on: November 28,2024

Investigating specific pathological features of cerebral cavernous malformation in children

by Katie Paradis,Children's Hospital BostonCredit: CC0 Public DomainChildren with cavernous malformations face unique treatment challenges due to factors such as the malformation's locat

Updated on:November 28,2024

Report highlights scale of dementia epidemic in Africa

by King's College LondonCredit: King's College LondonAlzheimer's Disease International (ADI) has published its first report on the impact of dementia in sub-Saharan Africa (SSA), at i

Updated on: April 29,2024

Report highlights scale of dementia epidemic in Africa

by King's College LondonCredit: King's College LondonAlzheimer's Disease International (ADI) has published its first report on the impact of dementia in sub-Saharan Africa (SSA), at i

Updated on:April 29,2024

The link between memory perceptions and Alzheimer's risk

by Kristie Auman-Bauer,Pennsylvania State UniversityCredit: AI-generated imageOver 20 percent of older adults suffer from subjective memory impairment, where a person reports having trouble reme

Updated on: June 18,2024

The link between memory perceptions and Alzheimer's risk

by Kristie Auman-Bauer,Pennsylvania State UniversityCredit: AI-generated imageOver 20 percent of older adults suffer from subjective memory impairment, where a person reports having trouble reme

Updated on:June 18,2024

Study reveals insights into link between genetic mutation and Parkinson's

by Bill Hathaway,Yale UniversityLRRK2 inhibits lysosomal protease activity in human iPSC-derived macrophages. (A) Airyscan live cell confocal micrographs showing lysosome labeling in human iPSC-

Updated on: April 26,2024

Study reveals insights into link between genetic mutation and Parkinson's

by Bill Hathaway,Yale UniversityLRRK2 inhibits lysosomal protease activity in human iPSC-derived macrophages. (A) Airyscan live cell confocal micrographs showing lysosome labeling in human iPSC-

Updated on:April 26,2024

Optimizing chronic subdural hematoma treatment

by Cactus CommunicationsThe MRCSDH is the first nationwide study in mainland China to assess the safety and efficacy of different treatment approaches for CSDH. Its findings can help the medical commu

Updated on: April 06,2024

Optimizing chronic subdural hematoma treatment

by Cactus CommunicationsThe MRCSDH is the first nationwide study in mainland China to assess the safety and efficacy of different treatment approaches for CSDH. Its findings can help the medical commu

Updated on:April 06,2024

Post-COVID condition is not linked to ongoing infection or active brain damage, study shows

by Gustav Löfgren,Swedish Research CouncilPrincipal component analysis plot of 5 neurobiomarkers in CSF. The centroids for each group are indicated and surrounded with ellipses indicating 95% co

Updated on: January 11,2024

Post-COVID condition is not linked to ongoing infection or active brain damage, study shows

by Gustav Löfgren,Swedish Research CouncilPrincipal component analysis plot of 5 neurobiomarkers in CSF. The centroids for each group are indicated and surrounded with ellipses indicating 95% co

Updated on:January 11,2024

Stem cell scientists develop game-changing organoid model to study human cerebellar development and disease

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainIn a first for USC Stem Cell scientists, the laboratory of Giorgia Quadrato has pioneered a novel human brain organoid model that

Updated on: January 09,2024

Stem cell scientists develop game-changing organoid model to study human cerebellar development and disease

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainIn a first for USC Stem Cell scientists, the laboratory of Giorgia Quadrato has pioneered a novel human brain organoid model that

Updated on:January 09,2024

Tips to making your home safer for people with Alzheimer's

by Ernie MundellBright lights, loud sounds and trip hazards can make a person with Alzheimer's uncomfortable in the home and even pose real dangers.The Alzheimer's Foundation of America (AFA)

Updated on: June 15,2024

Tips to making your home safer for people with Alzheimer's

by Ernie MundellBright lights, loud sounds and trip hazards can make a person with Alzheimer's uncomfortable in the home and even pose real dangers.The Alzheimer's Foundation of America (AFA)

Updated on:June 15,2024

Epigenetic markers associated with Alzheimer's disease found

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers from the Brigham and Women's Hospital, Harvard Medical School and the Dana-Farber Cancer Institute in the U.S., and Shan

Updated on: June 01,2024

Epigenetic markers associated with Alzheimer's disease found

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers from the Brigham and Women's Hospital, Harvard Medical School and the Dana-Farber Cancer Institute in the U.S., and Shan

Updated on:June 01,2024

Uncovering potential pathway to slowing Alzheimer's

by University of Technology, SydneyCredit: Unsplash/Micheile HendersonIf we can overcome the loss of a process in the brain called "RNA editing," we may be able to slow the progress of

Updated on: June 01,2024

Uncovering potential pathway to slowing Alzheimer's

by University of Technology, SydneyCredit: Unsplash/Micheile HendersonIf we can overcome the loss of a process in the brain called "RNA editing," we may be able to slow the progress of

Updated on:June 01,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on: April 02,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on:April 02,2024

Research offers insight into future understanding of MS and its treatments

byTrinity College DublinComparison of EBNA-1 IgG Levels in Healthy Controls and People With MS and Epilepsy. Credit:Neurology Neuroimmunology & Neuroinflammation(2024). DOI: 10.1

Updated on: April 06,2024

Research offers insight into future understanding of MS and its treatments

byTrinity College DublinComparison of EBNA-1 IgG Levels in Healthy Controls and People With MS and Epilepsy. Credit:Neurology Neuroimmunology & Neuroinflammation(2024). DOI: 10.1

Updated on:April 06,2024